1,755 filings
Page 20 of 88
FWP
dg5p xic4siuwiwe4
19 Jul 16
Free writing prospectus
12:00am
424B5
do9g d2c8a
18 Jul 16
Prospectus supplement for primary offering
12:00am
POSASR
8f8fti581ezzgcp9tzsl
13 Jul 16
Automatic shelf registration (post-effective amendment)
12:00am
6-K
rcksrm61in06q5
13 Jul 16
Current report (foreign)
12:00am
6-K
693g0ly
13 Jul 16
First Amendment to Master Purchase Agreement
12:00am
6-K
vyc8gmg3 nlgaxl1
13 Jul 16
Current report (foreign)
12:00am
FWP
r65xl 7kn8ev00j
13 Jul 16
Free writing prospectus
12:00am
FWP
k5pt60ok747vnd8gt8
12 Jul 16
Free writing prospectus
12:00am
6-K
u0fmcd04 3w0
12 Jul 16
Live Filing
12:00am
6-K
uabw8t
5 Jul 16
Live Filing
12:00am
6-K
mc8hj2my
28 Jun 16
Teva Announces FDA Acceptance of New Drug Applications for Fluticasone Propionate/Salmeterol and Fluticasone Propionate RespiClick® Inhalers
12:00am
6-K
qq8jwc
27 Jun 16
Teva and Antares Pharma Announce Launch of Generic Imitrex® In the United States
12:00am
6-K
ayif5aig0x
24 Jun 16
Live Filing
12:00am
6-K
izmxx281w o1r
23 Jun 16
Live Filing
12:00am
6-K
1vjbp57d5 lrprc
20 Jun 16
Teva to Present Data Highlighting SD-809 at 20th International Congress of Parkinson’s Disease and Movement Disorders
12:00am
6-K
ar8wd4nfzydudg9d
13 Jun 16
Live Filing
12:00am
6-K
m43by25kz5 x2y82
10 Jun 16
Teva Announces Favorable Court Ruling in TREANDA® (bendamustine hydrochloride) Patent Infringement Litigation
12:00am
6-K
j2o y43mv7ebj4
7 Jun 16
Committees voted that if approved, VANTRELA ER should be labeled as an abuse-deterrent product by the oral, nasal, and intravenous routes of abuse
12:00am
6-K
2k1remf8thcw d09m3ow
7 Jun 16
Teva to Present at the Jefferies 2016 Healthcare Conference
12:00am
6-K
gopeufpqm7ahub7 wz
6 Jun 16
Teva to Present at the Goldman Sachs 37th Annual Global Healthcare Conference
12:00am